Replozyl

Client: Bristol Myers Squibb
Agency: CDMP
Role: Senior Art Director

Challenge:
The launch of Reblozyl, a treatment for myelodysplastic syndrome (MDS)-related anemia, required a compelling visual identity and a suite of marketing materials to effectively communicate the drug’s benefits. The challenge was to develop engaging, data-driven designs that would resonate with healthcare professionals (HCPs) and sales teams, ensuring clarity and impact across both digital and print platforms.

Solution:
As Senior Art Director at CDMP, I played a key role in shaping Reblozyl’s brand presence by creating visually striking and informative assets, including: infographics and data visualizations, ad banners, digital and print sales aids.